When it comes to growth shares I think Australian investors are spoilt for choice. At this point in time the local share market is home to a great number of high-quality shares exhibiting high levels of earnings growth potential.
Here are 10 which I think could provide investors with market-beating gains in the long term:
a2 Milk Company Ltd (Australia) (ASX: A2M)
This fast-growing dairy company has been growing like a weed in the last few years. Thanks to the insatiable demand for its products from Chinese consumers, I believe there is still significant growth ahead for the company. Its shares may look expensive after rallying around 45% year-to-date, but I believe patient buy and hold investors will be rewarded handsomely.
Altium Limited (ASX: ALU)
I believe Altium will be a big winner from the rise of the Internet of Things. As the majority of these connected devices require printed circuit boards (PCB) inside them, I expect demand for Altium's PCB design software will grow strongly. Management certainly believes it will and expects to double revenue to US$200 million by 2020.
Appen Ltd (ASX: APX)
Thanks to the strong demand for its voice recognition and language data services from government agencies, automakers, and major technology companies, I believe Appen has a bright future. After a strong start to FY 2017, management expects full-year earnings growth in excess of 20%.
Domino's Pizza Enterprises Ltd (ASX: DMP)
This pizza chain operator's share price is currently trading around 22% lower than its 52-week high of $80.69 due partly to a sell-off related to concerns over allegations of the underpayment of staff by franchisees. I believe these concerns have been overblown and that the decline in its share price provides investors with a compelling risk/reward.
Mayne Pharma Group Ltd (ASX: MYX)
Like Domino's, Mayne Pharma has also seen its share price plunge in the last few months. Allegations of price-fixing by the U.S. Department of Justice and concerns over the impact the Trump Administration will have on the industry appear to be behind the fall. But at just 13x annualised earnings, I feel Mayne Pharma's shares have been oversold and could be a bargain buy.
Nanosonics Ltd. (ASX: NAN)
I think this infection control company would be a fantastic buy and hold investment thanks largely to the growing popularity of its ultrasound probe disinfection system. Nanosonics recently reported a 131% jump in half-year sales to $36.1 million and I expect more of the same in the second half.
Nextdc Ltd (ASX: NXT)
As more and more businesses migrate to the cloud, I believe this data centre operator will see demand for its services increase greatly. NextDC recently reported a 32% rise in contracted utilisation to 30 megawatts during the first-half of FY 2017. This led to the company posting an incredible 110% increase in half-year EBITDA to $23.9 million.
Ramsay Health Care Limited (ASX: RHC)
This private hospital operator would have to be my favourite buy and hold investment option on the Australian share market. Thanks to its global footprint, I believe Ramsay is positioned perfectly to profit from ageing populations and increased chronic disease burden across the world.
Webjet Limited (ASX: WEB)
This online travel agent could be the Australian share market's ultimate growth share in my opinion. Thanks to market share gains and bookings growth from all of its businesses, Webjet recently reported a 96% jump in half-year net profit after tax. I remain confident that there will be more of the same in the second half.
XERO FPO NZX (ASX: XRO)
Xero is a provider of cloud-based accounting software for small to medium enterprises. Although the space is extremely competitive, the company has been growing its user numbers at an extraordinarily quick rate and just broke through the 1 million mark for subscribers. Despite this stellar growth, I still believe there is a significant opportunity for the company to grow globally.
